siRNA, Anti-IRAK1, LNA-modified(CAT#: SIRGT14351WQ-LNA)

The product SIRGT14351WQ-LNA is a type of small interfering RNA (siRNA) that targets IRAK1 gene and regulates the expression of gene. The siRNA interferes with the expression of IRAK1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001025242.1; NM_001025243.1; NM_001569.3
Alternative Names IRAK; pelle
Related Diseases Pediatric Systemic Lupus Erythematosus, Mumps
Purification HPLC
Target Gene
Gene ID 3654
Uniprot ID P51617

Related Products